$76.9 M

IMI Mkt cap, 14-Jun-2018

$9.7 M

Intermolecular Revenue Q1, 2018
Intermolecular Gross profit (Q1, 2018)6.3 M
Intermolecular Gross profit margin (Q1, 2018), %65.1%
Intermolecular Net income (Q1, 2018)-623 K
Intermolecular EBIT (Q1, 2018)-815 K
Intermolecular Cash, 31-Mar-20184.4 M

Intermolecular Financials

Intermolecular Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

67.4 m47.7 m45.3 m47.3 m

Revenue growth, %

(29%)(5%)4%

Cost of goods sold

32.5 m24.7 m19.3 m15.8 m

Gross profit

34.9 m23 m26 m31.5 m

Gross profit Margin, %

52%48%57%67%

Sales and marketing expense

7.4 m

R&D expense

28.1 m

General and administrative expense

10.7 m

Operating expense total

46.2 m

EBIT

(8 m)(21 m)(20.7 m)(15.9 m)

EBIT margin, %

(12%)(44%)(46%)(34%)

Interest expense

830 k682 k267 k173 k

Interest income

173 k

Pre tax profit

(8.8 m)(21.8 m)(21 m)(15.4 m)

Income tax expense

17 k7 k8 k7 k

Net Income

(8.8 m)(21.8 m)(21 m)(15.4 m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Revenue

17.7 m15.9 m9.9 m10.9 m9.8 m11 m11.5 m14.5 m11.7 m10.6 m9.9 m8.1 m9.7 m

Cost of goods sold

9.1 m6.6 m5.6 m6.2 m5.5 m4.6 m5 m4.8 m4.1 m3.5 m3 m2.5 m3.4 m

Gross profit

8.7 m9.3 m4.3 m4.7 m4.4 m6.4 m6.5 m9.7 m7.6 m7.1 m7 m5.5 m6.3 m

Gross profit Margin, %

49%59%43%43%44%58%56%67%65%67%70%69%65%

Sales and marketing expense

1.5 m1.6 m1.4 m1.3 m1.3 m1.6 m1.6 m1.9 m2.1 m1.8 m1.5 m931 k796 k

R&D expense

6.1 m7 m6.2 m5 m6.5 m7.2 m7.4 m6.9 m6.9 m8.5 m7.1 m5.4 m4 m

General and administrative expense

3 m3.3 m3.1 m3.1 m3.4 m3.2 m3.2 m2.6 m2.7 m2.7 m3 m2.2 m2.3 m

Operating expense total

10.7 m13 m11 m9.5 m11.2 m11.9 m12.2 m11.4 m11.7 m14 m12.9 m8.5 m7.1 m

EBIT

(2 m)(3.6 m)(6.7 m)(4.8 m)(6.9 m)(5.6 m)(5.8 m)(1.7 m)(4.1 m)(6.9 m)(6 m)(3 m)(815 k)

EBIT margin, %

(11%)(23%)(67%)(44%)(70%)(51%)(50%)(12%)(35%)(65%)(60%)(37%)(8%)

Interest expense

168 k194 k179 k159 k134 k121 k52 k32 k40 k51 k55 k58 k106 k

Interest income

32 k40 k51 k55 k58 k106 k

Pre tax profit

(2.1 m)(3.8 m)(6.9 m)(5 m)(7 m)(5.7 m)(5.8 m)(1.7 m)(4 m)(6.8 m)(5.8 m)(2.9 m)(622 k)

Income tax expense

26 k4 k2 k1 k3 k2 k2 k3 k1 k3 k800 1 k800

Net Income

(2.2 m)(3.9 m)(6.9 m)(5 m)(7 m)(5.7 m)(5.8 m)(1.7 m)(4 m)(6.8 m)(5.8 m)(2.9 m)(623 k)

Intermolecular Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

72.1 m21.8 m11.7 m5.8 m

Inventories

2.2 m1.8 m1.6 m1.4 m

Current Assets

81.4 m72.2 m43.1 m32.3 m

PP&E

28.5 m19.1 m15.7 m11 m

Total Assets

124.5 m105.4 m69.7 m53.2 m

Accounts Payable

2.2 m862 k848 k309 k

Current Liabilities

14 m10.1 m10.2 m5 m

Total Liabilities

8.2 m

Additional Paid-in Capital

194.9 m202.1 m209 m213.3 m

Retained Earnings

(110.1 m)(131.9 m)(152.9 m)(168.3 m)

Total Equity

56.1 m45 m

Financial Leverage

1.2 x1.2 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Cash

74.3 m72.3 m41.8 m22.1 m25.6 m14.4 m3.3 m17.1 m16.4 m9.7 m7.6 m6.5 m4.4 m

Accounts Receivable

2.8 m4.2 m

Inventories

7.5 m7.3 m7.4 m

Current Assets

87.8 m79.3 m76 m74 m68.9 m66.6 m43.5 m35.9 m37.9 m34.5 m32.6 m25.5 m32.4 m

PP&E

27.4 m26.7 m24.5 m21.7 m18 m16.5 m16.1 m15.4 m14.4 m12 m9.8 m8.6 m4.9 m

Total Assets

127.8 m122 m116.2 m111.4 m100.4 m96.2 m71.6 m66.6 m64 m57.1 m50 m46.5 m43.2 m

Accounts Payable

3.8 m615 k1.1 m221 k617 k1.1 m1.8 m224 k786 k327 k746 k1 m399 k

Current Liabilities

40.3 m11.4 m11.5 m10.4 m10.4 m10.6 m10.5 m7 m7.5 m6.5 m7 m6.1 m4.1 m

Total Liabilities

40.6 m38.6 m38.1 m36.6 m34.7 m34.4 m14.2 m10.3 m10.8 m9.8 m10.2 m9.2 m7 m

Additional Paid-in Capital

192.8 m197.3 m198.9 m200.6 m204.6 m206.4 m207.8 m210.8 m211.7 m212.6 m214 m214.3 m215.1 m

Retained Earnings

(105.7 m)(114 m)(120.8 m)(125.8 m)(138.9 m)(144.6 m)(150.4 m)(154.6 m)(158.6 m)(165.3 m)(174.2 m)(177 m)(178.9 m)

Total Equity

65.7 m61.8 m57.4 m56.3 m53.2 m47.3 m39.8 m37.3 m36.2 m

Financial Leverage

1.5 x1.6 x1.2 x1.2 x1.2 x1.2 x1.3 x1.2 x1.2 x

Intermolecular Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(8.8 m)(21.8 m)(21 m)(15.4 m)

Depreciation and Amortization

10.9 m

Accounts Receivable

1.7 m1.1 m

Inventories

2.2 m1.6 m1.6 m

Accounts Payable

2.2 m(635 k)848 k(493 k)

Cash From Operating Activities

(6.2 m)(1.9 m)(10.1 m)(5.4 m)

Purchases of PP&E

(2.8 m)(2.4 m)

Cash From Investing Activities

(47.7 m)(1.2 m)

Cash From Financing Activities

(810 k)701 k

Interest Paid

666 k9 k

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018

Net Income

(2.2 m)(3.9 m)(6.9 m)(5 m)(7 m)(5.7 m)(5.8 m)(1.7 m)(4 m)(6.8 m)(5.8 m)(623 k)

Depreciation and Amortization

2.5 m

Accounts Receivable

425 k1.8 m

Inventories

7.3 m7.4 m445 k

Accounts Payable

1.1 m221 k(284 k)1.1 m1.8 m224 k786 k327 k746 k(554 k)

Cash From Operating Activities

(1.8 m)1.7 m

Purchases of PP&E

(927 k)(194 k)

Cash From Investing Activities

5.7 m(3.4 m)

Cash From Financing Activities

37 k17 k

Interest Paid

191 k

Intermolecular Ratios

USDY, 2018

Financial Leverage

1.2 x
Report incorrect company information